Early career · publishing since 2021
Myeloproliferative Neoplasms: Diagnosis and TreatmentEndoplasmic Reticulum Stress and DiseaseChronic Myeloid Leukemia TreatmentsCancer, Hypoxia, and MetabolismCancer Cells and Metastasis
Publications
17
Citations
15
Est. group size
—
Recurring co-author estimate
Active years
6
Publishing since 2021
In context
Among 1,353 early career Medicine PIs within our index
Citations: 15p25 74 · p75 317 · cohort median 157
Publications / year (recent): 2.4p25 1.8 · p75 4.4 · cohort median 2.6
Typically publishes in teams of ~26 · 9% small-team papers (≤3 authors) · across 4 venues
Publication cadence
Publications per year over the last 10 years — averaging 2.4/year recently
Recent publications
- Investigation into the Evolution of Medical School Applications from 2021 Through 2024
Michigan Journal of Medicine · 2026
- Data from Type I but Not Type II Calreticulin Mutations Activate the IRE1α/XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative Neoplasms
2023
- Supplementary Data from Type I but Not Type II Calreticulin Mutations Activate the IRE1α/XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative Neoplasms
2023
- Data from Type I but Not Type II Calreticulin Mutations Activate the IRE1α/XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative Neoplasms
2023
- Supplementary Data from Type I but Not Type II Calreticulin Mutations Activate the IRE1α/XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative Neoplasms
2023
- Abstract LB134: Type 1 calreticulin mutations differentially activate the IRE1α-XBP1 pathway of the unfolded protein response to drive myeloproliferative neoplasms
Cancer Research · 2022
- Type 2 but Not Type 1 Calreticulin Mutants Exhibit Loss of Chaperone Function Due to C-Terminal Structural Interference, and Bind to Wild Type Calreticulin in a Dominant Negative Manner
Blood · 2022
- Type I Calreticulin Mutations Result in Hyperactivation of Its Acetyltransferase Function and Iron Metabolism, Inducing a Susceptibility to Ferroptosis
Blood · 2021
- Myeloproliferative Neoplasm-Associated Type 2 Calreticulin Mutations Differentially Activate and Depend on the ATF6 Pathway of the UPR
Blood · 2021
- Type 1 Calreticulin Mutations Differentially Activate the IRE1α-XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative Neoplasms
Blood · 2021
- Type 1 Calreticulin Mutations Differentially Activate the IRE1 alpha-XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative Neoplasms
RWTH Publications (RWTH Aachen) · 2021
Publishes in
- Blood×4
- Michigan Journal of Medicine×2
- Frontiers in Oncology×1
- Molecular Cell×1
- Research Square×1
Similar researchers
By research-topic overlap
- Veena Fauble
Medicine · University of Michigan
- Kristen Pettit
Medicine · University of Michigan
- James Yoon
Medicine · University of Michigan
- Andrea Sipos
Medicine · University of Michigan
- Malathi Kandarpa
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile